Results 111 to 120 of about 8,454 (202)

A Case of Methemoglobinemia Suspected to Be Induced by Rabeprazole. [PDF]

Acute Med Surg
Kawasaki R, Toida C, Kamijo H, Akita M, Hattori M, Ichikawa M, Takayama H, Miyama H, Nitta K, Imamura H.   +9 more
europepmc   +1 more source

Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole [PDF]

, 2005
Sivero, L.
core  

Potential clinical indications for a CCK2 receptor antagonist [PDF]

, 2016
Boyce, Malcolm, Lloyd, Katie A, Pritchard, D Mark   +2 more
core   +1 more source

Rabeprazole attenuates fibrosis by modulating SMAD3 linker region phosphorylation. [PDF]

Biomed Rep
Li L, Liang Z, Fan L, Cao Y, Tang X, Chen J.   +5 more
europepmc   +1 more source

Efficacy of 10 days high-dose and double-dose rabeprazole-based concomitant therapy for Helicobacter pylori eradication among Lebanese population: a pilot randomized controlled trial. [PDF]

BMC Gastroenterol
Elias M, Yazbeck C, Zaarour A, Sleiman V, Sakr N, Raad G, Akiki B.   +6 more
europepmc   +1 more source

Proton pump inhibitors and the risk of urolithiasis: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Guo J, Chen X, Dou Y, Xiong Y, Zhao T.
europepmc   +1 more source

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Almabruk BA, Alsulami GA, Alzahrani A, Alsulami EA, Badawood AA, Alghanim AS, Alresheedi FF, Alharbi RS, Alghamdi HA.   +8 more
europepmc   +1 more source

Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for <i>Helicobacter pylori</i> eradication: a systematic review and network meta-analysis. [PDF]

BMJ Open Gastroenterol
Taufiqqurrachman I, Syam AF, Maulahela H, Abdullah M, Matsumoto T, Miftahussurur M, Yamaoka Y.   +6 more
europepmc   +1 more source

Comparative efficacy and safety of potassium-competitive acid blockers and proton pump inhibitors for erosive esophagitis: a network meta-analysis of randomized controlled trials. [PDF]

EClinicalMedicine
Al Hayek M, Lucendo AJ, Barberio B, Yadlapati R, Nounou MV, Beshr MS, Gyawali CP, Chan WW, Salama AH, Elhadi M, Savarino EV, Laine L.   +11 more
europepmc   +1 more source

A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias. [PDF]

J Clin Med
Wu B, He Z, Xu T.
europepmc   +1 more source